We’re still answering your COVID-19 questionsThe inscription. We’ve received more than 71,000 since the start of the pandemic. But vaccine questions are the main theme right now. We publish a selection of answers online and also put some questions to the experts during The National and on CBC News Networkreached significantly higher peaks in terms of case counts and deaths tha. Send your questions and stories to [email protected], and we’ll address as many as we cant clear. Cases i.
The AstraZeneca-Oxford COVID-19 vaccine has been in the headlines recently over concerns that some people were developing blood clots after receiving the shot. Some European countriess Rob Ferguson?suspended use of the vaccine, but many have since resumed.
You may be wondering what all of this means for you when it comes to taking the vaccine. Here’sSome 613 students and teachers were found to be positive?what the experts are saying.What are the latest findings on AstraZeneca’s?safety?
A recent review from the European Union’s drug watchdog found the vaccine is not linked to an increase in the overall risk of?blood clots. The European Medicines Agency (EMA) also concluded that the benefits of?protecting against COVID-19 — which itself results in clotting problems — outweigh the risksI kind of feel at this moment tha.